` LNTH (Lantheus Holdings Inc) vs S&P 500 Comparison - Alpha Spread

LNTH
vs
S&P 500

Over the past 12 months, LNTH has underperformed S&P 500, delivering a return of -3% compared to the S&P 500's 12% growth.

Stocks Performance
LNTH vs S&P 500

Loading

Performance Gap
LNTH vs S&P 500

Loading
LNTH
S&P 500
Difference

Performance By Year
LNTH vs S&P 500

Loading
LNTH
S&P 500
Add Stock

Competitors Performance
Lantheus Holdings Inc vs Peers

S&P 500
LNTH
ALC
7741
COLO B
ALGN
Add Stock

Lantheus Holdings Inc
Glance View

Economic Moat
Wide
Market Cap
5.4B USD
Industry
Health Care

Lantheus Holdings Inc. is a captivating player in the healthcare sector, primarily operating within the niche of diagnostic medical imaging. The company's core mission revolves around enhancing diagnosis and treatment pathways, thus playing an integral role in patient care. At the heart of Lantheus's operations are its innovative diagnostic and therapeutic products, including radiopharmaceuticals and contrast agents that physicians rely on to obtain detailed images of the body's organs and tissues. Through a combination of proprietary technologies and strategic partnerships, Lantheus delivers solutions that help medical professionals make more informed clinical decisions, ultimately aiming to improve patient outcomes. This business generates revenue by developing, manufacturing, and commercializing its products, which are utilized across hospitals, clinics, and research centers worldwide. By consistently investing in research and development, Lantheus ensures a competitive edge through a robust pipeline of next-generation imaging agents. Strategic alliances and collaborative ventures further fortify its market presence, allowing the company to expand its reach and integrate new advancements into its product offerings. This commitment to innovation and collaboration has not only cemented its reputation in the life sciences industry but also ensures a steady and growing stream of income from its well-regarded product lines.

LNTH Intrinsic Value
140.55 USD
Undervaluation 44%
Intrinsic Value
Price
Back to Top